As the spring saw another surge of coronavirus cases across the country, healthcare officials are urging people to get vaccinated. But some social media posts are spreading false claims that the ...

A third dose of the Pfizer/BioNTech COVID-19 vaccine can "strongly" boost protection against the delta variant -- beyond the protection afforded by the standard two doses, suggests new data released ...

It comes days before the FDA's advisory committee will discuss booster shots. The Food and Drug Administration on Wednesday released data from Pfizer's application for COVID-19 vaccine booster doses.

Pfizer-BioNTech is postponing its rolling application to the Food and Drug Administration to expand the use of its two-dose Covid-19 vaccine for children ages 6 months to 4 years. The move means that ...

American pharma giant Pfizer ($PFE) leads the pack as pharmaceutical companies plan price increases for at least 350 branded ...

NEW YORK & MAINZ, GERMANY--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced positive topline results from a Phase 1/2 study (NCT05596734) evaluating the safety, ...

Pfizer recently announced its guidance for 2026. One thing seems clear: Its financial results won't get much stronger. It ...

Pfizer is close to submitting data to the Food and Drug Administration on a fourth dose of its Covid-19 vaccine, according to CEO Albert Bourla. “Clearly there is a need in an environment of omicron ...

The FDA said Pfizer had collected more data that was necessary to review. The Food and Drug Administration on Friday postponed its review of Pfizer’s COVID-19 vaccine for kids under 5. “We realized ...

Pfizer (PFE) stock has attracted fresh attention after recent trading left its one-month return at a 3.3% decline and its ...

Pfizer-BioNTech submitted data to the Food and Drug Administration to clear its Covid-19 vaccine for use in children ages 5 to 11, officials announced Tuesday. The FDA is expected to take at least ...